Medical devices, healthcare technology and the business of care
510(k) clearance · K260063

GSPE Spacer

The General Hospital Corporation, d/b/a Massachusetts · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK260063

What did the FDA decide?

FDA recorded a September 11, 2026 substantial-equivalence decision for K260063, the GSPE Spacer from The General Hospital Corporation doing business as Massachusetts General Hospital. The summary describes a single-use knee spacer with femoral and tibial components. The femoral component is available in gentamicin-sulfate-blended UHMWPE or cobalt-chrome alloy; the tibial component uses gentamicin-sulfate-blended UHMWPE. FDA's documents list Class II, regulation 888.3560 and product codes JWH and MBB.

The summary assigns different primary predicates to the two configurations: The Knee Spacer (REMEDY Knee Spacer), K112470, for the All-GSPE Spacer, and the Rx Knee System, K240683, for the CoCr-GSPE Spacer. It lists wear, elution, antibacterial activity, stability and biocompatibility testing, and states that performance results support substantial equivalence. The excerpts do not provide numerical test results. This explanation preserves the configuration-specific predicate relationships without converting the submission's testing conclusion into an independent clinical assessment.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260063
Regulatory pathway
510(k) premarket notification
Product code
JWH
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer.

Product code
JWH
FDA device class
2

FDA decision timeline

  1. K260063 received

    Application receipt date recorded by FDA.

  2. K260063 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JWH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

The General Hospital Corporation, d/b/a Massachusetts

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Somerville, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records